Global Health

Global Health

1,331.40
-24.00
(-1.77%)
Market Cap
36,404.30 Cr
EPS
17.92
PE Ratio
70.04
Dividend Yield
0.04 %
52 Week High
1,393.20
52 Week Low
935.50
PB Ratio
10.72
Debt to Equity
0.36
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from11 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+63.64 %
+63.64 %
Hold
Hold+18.18 %
+18.18 %
Sell
Sell+18.18 %
+18.18 %

Company News

View All News
Caret
neutral
Global Health Limited Schedules Board Meeting on August 7 to Approve Quarterly Financial ResultsToday
Global Health Limited has scheduled a Board of Directors meeting on August 7, 2025, to consider and approve the unaudited financial results for the quarter ended June 30, 2025. The company's trading window is closed from July 1, 2025, and will reopen 48 hours after the results declaration. The company trades on BSE with scrip code 543654 and on NSE with symbol MEDANTA.
positive
Global Health Limited (Medanta) has received approval from the Assam Cabinet for allotment of 3.5 acres of land on long-term lease for a hospital project in Guwahati. The lease terms include a 60-year duration with an option for 30-year renewal, requiring an upfront land lease charge of Rs. 56 crore and ongoing estate charges of Rs. 2.42 per square meter per month. This 3.5-acre land allocation replaces an earlier offer of 3 acres from Assam Electricity Grid Corporation Limited, following the company's request for substitution with suitable highway-adjacent land. The Cabinet also approved a common Floor Area Ratio (FAR) for the entire land parcel comprising two hospitals and one hotel. Medanta is awaiting further details from relevant agencies and will proceed with execution of agreements.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,274.30
#1 1,22,237.70
108.01
7,184.10
18.77
1,076
26.84
53.37
7,456.00
1,05,775.20
73.16
#1 21,794.00
14.74
1,513
60.41
53.50
850.60
63,888.30
75.79
7,849.70
8.99
809
-7.43
69.85
1,987.00
40,694.40
51.05
5,482.98
10.96
807
3.41
53.22
1,331.40
#5 36,404.30
#4 70.04
#6 3,692.32
#1 25.09
#6 486
#9 -20.35
70.28
749.85
30,852.70
81.93
3,035.10
12.94
409
48.39
66.13
591.50
29,861.90
80.45
4,138.46
22.85
#1 5,417
#1 3,986.36
42.71
1,525.10
15,647.10
60.63
1,566.90
17.46
244
35.52
52.97
1,439.00
9,431.00
#1 49.93
1,290.20
17.77
194
-0.88
37.92
586.95
7,893.70
177.70
2,218.14
12.97
28
-71.06
53.62

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
25.09 %
Net Income Growth
66.21 %
Cash Flow Change
-5.03 %
ROE
10.63 %
ROCE
12.64 %
EBITDA Margin (Avg.)
10.54 %

Quarterly Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
492
588
593
533
627
695
706
732
795
865
855
836
883
975
960
954
Expenses
386
442
448
441
485
523
534
540
595
631
621
629
675
728
706
757
EBITDA
106
146
146
92
142
172
172
192
199
234
234
207
208
247
254
198
Operating Profit %
21 %
24 %
23 %
15 %
21 %
23 %
23 %
24 %
24 %
25 %
26 %
22 %
22 %
24 %
25 %
19 %
Depreciation
31
31
33
35
36
37
39
38
40
43
44
46
47
49
49
49
Interest
16
17
18
28
19
18
21
21
18
20
18
18
18
16
16
15
Profit Before Tax
58
98
95
29
87
117
112
133
141
171
172
143
144
181
189
133
Tax
16
31
25
12
28
31
32
32
39
45
49
16
37
50
46
32
Net Profit
42
67
70
18
59
86
81
101
102
125
124
127
106
131
143
101
EPS in ₹
5.13
13.22
2.76
0.69
2.32
3.38
3.08
3.77
3.80
4.66
4.61
4.74
3.96
4.87
5.32
3.77

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,984
2,430
2,666
2,694
3,146
4,116
4,304
4,766
Fixed Assets
1,094
1,194
1,703
1,616
1,776
2,050
2,236
3,047
Current Assets
472
489
479
502
812
1,580
1,509
1,533
Capital Work in Progress
317
666
382
464
439
327
388
529
Investments
0
0
0
0
0
0
0
67
Other Assets
573
570
582
615
930
1,739
1,681
0
Total Liabilities
1,984
2,430
2,666
2,694
3,146
4,116
4,304
4,766
Current Liabilities
334
296
358
405
420
573
618
619
Non Current Liabilities
432
839
959
907
1,110
1,115
781
760
Total Equity
1,217
1,296
1,350
1,382
1,616
2,428
2,906
3,386
Reserve & Surplus
1,136
1,214
1,268
1,300
1,565
2,375
2,852
3,333
Share Capital
81
49
49
50
51
54
54
54

Cash Flow

Cash Flow
2015
2016
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
-20
3
14
87
-78
50
648
-343
Investing Activities
-126
-241
-69
-249
-87
-239
-421
-342
-441
Operating Activities
213
228
63
166
175
242
311
645
612
Financing Activities
-88
-7
9
97
-1
-81
160
346
-514

Share Holding

% Holding
Sept 2021
Oct 2022
Nov 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
35.04 %
35.03 %
33.08 %
33.08 %
33.08 %
33.07 %
33.06 %
33.05 %
33.04 %
33.04 %
33.04 %
33.03 %
33.03 %
33.01 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.69 %
0.00 %
12.09 %
12.94 %
12.20 %
12.47 %
11.76 %
11.54 %
DIIs
0.00 %
0.00 %
7.78 %
12.55 %
12.35 %
10.80 %
10.93 %
9.68 %
10.25 %
10.57 %
11.11 %
10.51 %
11.93 %
12.20 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
25.44 %
6.16 %
5.77 %
6.79 %
6.85 %
6.79 %
7.14 %
6.28 %
6.54 %
6.74 %
6.53 %
6.48 %
Others
64.96 %
64.97 %
33.69 %
48.21 %
48.80 %
49.34 %
38.48 %
50.48 %
37.47 %
37.16 %
37.10 %
37.24 %
36.75 %
36.77 %
No of Share Holders
47
48
2,86,944
1,21,407
1,07,120
1,09,798
1,16,627
1,24,775
1,66,253
1,55,307
1,49,722
1,48,633
1,54,688
1,56,372

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,203.60 1,241.80
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 1,001.20 1,042.50
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 1,073.35 1,032.55
19 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2024 1,191.50 1,113.90
03 Aug 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
03 Aug 2024 1,306.70 1,209.25

Announcements

Board Meeting Intimation for Intimation Under Regulation 29 Of Listing Regulations4 hours ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS4 days ago
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)4 days ago
Intimation Under Regulation 30 Of The Listing Regulations.6 days ago
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jul 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Closure of Trading WindowJun 27, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 23, 2025
Declaration Under Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 21, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
Key Performance Indicators (Kpis) For FY 2024-25May 15, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 15, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2025
Amendment In The Code Of Conduct Pursuant To Regulation 8 & 9 Of SEBI (Prohibition Of Insider Trading) Regulation 2015May 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 15, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 15, 2025
Results For The Quarter And Financial Year Ended March 31 2025May 15, 2025
Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI Listing RegulationMay 15, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 15, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesMay 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
Board Meeting Intimation for Board Meeting Intimation Regarding Approval Of Financial Results For The Quarter And Financial Year Ending March 31 2025 And Recommendation Of Final Dividend.May 05, 2025
Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI LODR RegulationApr 28, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesApr 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 14, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 08, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesApr 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Apr 07, 2025
Closure of Trading WindowMar 27, 2025

Technical Indicators

RSI(14)
Neutral
70.28
ATR(14)
Volatile
37.34
STOCH(9,6)
Neutral
62.37
STOCH RSI(14)
Neutral
51.85
MACD(12,26)
Bullish
5.23
ADX(14)
Strong Trend
33.17
UO(9)
Bearish
48.56
ROC(12)
Uptrend And Accelerating
6.00
WillR(14)
Overbought
-19.36

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Invesco India Mid Cap Fund Direct-Growth
2.51%
200000
-0.06%
-0.23%
HSBC Large and Mid Cap Fund Direct - Growth
0.10%
-127783
-0.38%
-1.03%
Invesco India Large & Mid Cap Fund Direct-Growth
2.23%
91000
-0.15%
-0.17%
Invesco India Flexi Cap Fund Direct - Growth
1.35%
53009
0.02%
-0.11%
Canara Robeco Large and Mid Cap Fund Direct-Growth
0.95%
50000
-0.06%
-0.08%
360 ONE FlexiCap Fund Direct - Growth
0.87%
46905
0.22%
0.87%
Invesco India Business Cycle Fund Direct-Growth
2.95%
44663
0.11%
0.30%
Invesco India Smallcap Fund Direct - Growth
2.42%
40288
-0.26%
-0.48%
Canara Robeco Multi Cap Fund Direct - Growth
0.72%
35000
0.02%
-0.03%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
0.00%
-33377
-1.20%
-1.35%
Canara Robeco Value Fund Direct - Growth
0.90%
20000
0.11%
0.08%
PGIM India Large and Mid Cap Fund Direct - Growth
1.19%
19430
0.20%
0.15%
HSBC Multi Asset Allocation Fund Direct - Growth
0.67%
-15467
-0.13%
-0.75%
360 ONE Balanced Hybrid Fund Direct - Growth
0.40%
9940
0.11%
0.40%
Nippon India Multi Asset Allocation Fund Direct - Growth
0.33%
9725
-0.02%
-0.04%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.20%
2138
0.03%
0.02%
Kotak Midcap Fund Direct-Growth
1.49%
2100
-0.18%
-0.32%
Motilal Oswal Nifty Midcap 150 Index Fund Direct - Growth
0.26%
1499
-0.02%
-0.04%
Nippon India Nifty Midcap 150 Index Fund Direct - Growth
0.26%
1109
-0.02%
-0.04%
JM Small Cap Fund Direct - Growth
0.00%
-1000
-0.02%
-1.45%
Tata Nifty MidSmall Healthcare Index Fund Direct - Growth
1.62%
652
-0.16%
-0.19%
SBI Nifty Midcap 150 Index Fund Direct - Growth
0.26%
526
-0.02%
-0.04%
ICICI Prudential Nifty Midcap 150 Index Fund Direct - Growth
0.26%
433
-0.02%
-0.04%
HDFC NIFTY Midcap 150 Index Fund Direct - Growth
0.26%
389
-0.02%
-0.04%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct - Growth
0.65%
-341
-0.08%
-0.07%

About Global Health

Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over 30 medical specialties, employed over 1,300 doctors, and had 2,467 installed beds across 4.7 million sq. ft. of area. The company operates hospitals in Gurugram, Indore, Ranchi, Lucknow, and Patna, with specialties including cardiology, neurosciences, oncology, and orthopedics. Global Health Limited went public in November 2022, raising Rs. 2205.57 crores through an IPO. The company has been expanding its facilities, adding beds, doctors, and new medical equipment across its hospitals.
Listing Date
16 Nov, 2022(2 Years, 43 days)
Chairperson NameNaresh Kumar Trehan